Diode laser. Ex vivo studies on vaporization and coagulation characteristics;Der diodenlaser. Ex-vivo-untersuchungen zu den vaporisations- und koagulationseigenschaften

Urologe - Ausgabe A

Volumn 46, Issue 9, 2007, Pages 1242-1247

  Seitz, M ^a   Ackermann, A ^a   Gratzke, C ^a   Schlenker, B ^a   Ruszat, R ^b   Bachmann, A ^b   Stief, C ^a   Reich, O ^a   Sroka, R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Urologische Klinik Universitatsspital Basel   (Switzerland)

Author keywords

Benign prostatic hyperplasia; Coagulation characteristics; Diode laser; Laser vaporization

Indexed keywords

ALUMINUM; PHOSPHATE; POTASSIUM; TITANIUM; YTTRIUM;

ANIMAL MODEL; ARTICLE; BLADDER NECK STENOSIS; BLEEDING; DIODE LASER; HEMOSTASIS; HOLMIUM LASER; KIDNEY PERFUSION; LASER SURGERY; LOW LEVEL LASER THERAPY; NONHUMAN; PROSTATE HYPERTROPHY; YAG LASER;

ANIMALS; EQUIPMENT DESIGN; HUMANS; KIDNEY; LASER COAGULATION; LASER THERAPY; LASERS, SOLID-STATE; MALE; PROSTATIC HYPERPLASIA; SWINE; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 34648816948     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1490-7     Document Type: Article

References (15)

1. Cooper, TE, Trezek GJ (1972) A probe technique for determining the thermal conductivity of tissue. J Heat Transfer 94: 133
2. Costello AJ, Bowsher WG, Bolton DM et al. (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69: 603-608
3. Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49: 87-91
4. Gilling PJ, Fraundorfer MR (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8: 11-15
5. Kaplan SA (2004) AUA Guidelines and their impact on the management of BPH: An update. Rev Urol 6(Suppl 9): 46-52
6. Kohrmann KU, Back W, Bensemann J et al. (1994) The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 8: 105-110
7. Kuntz RM (2006) Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 49: 961-969
8. Malek RS, Barrett DM Kuntzman RS (1998) High-power potassium-titanyl- phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51: 254-256
9. Michel MS, Kohrmann KU, Weber A et al. (1996) Rotoresect: new technique for resection of the prostate: experimental phase. J Endourol 10: 473-478
10. Montorsi F, Naspro R, Salonia A et al. (2004) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172: 1926-1929
11. Reich O, Bachmann A, Schneede P et al. (2004) Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171: 2502-2504
12. Reich O, Bachmann A, Siebels M et al. (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173: 158-160
13. Reich O, Schneede P, Corvin S et al. (2003) Combination of interstitial laser coagulation and transurethral resection of the prostate: ex vivo evaluations. Urology 61: 1172-1176
14. Reich O, Seitz M, Gratzke C et al. (2006) Benign prostatic syndrome (BPS). Ablative treatments. Urologe A 45: 769-782
15. Sulser T, Jochum W, Heitz PU et al. (1997) Histomorphological changes after neodymium: YAG laser-coagulation of the human prostate with the Side Focus fiber. Effect of power setting and time. Urol Res 1: 7-12